SCHEMBL27313684

SCHEMBL27313684

NCc1c[c]c(S(N)(=O)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.50
CA1 P00915 11/20 0.50
CA9 Q16790 10/20 0.50
CA12 O43570 8/20 0.50
CA14 Q9ULX7 6/20 0.50
CA7 P43166 5/20 0.50
CA5A P35218 5/20 0.50
CA4 P22748 4/20 0.50
CA6 P23280 4/20 0.50
CA5B Q9Y2D0 4/20 0.50
MAPT P10636 1/20 0.48
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PSIP1 O75475 1/20 0.38
LOXL2 Q9Y4K0 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
F2 P00734 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18230025 0.82 PSIP1 (0.41) CA2CA1CA9CA12CA14
SCHEMBL27828065 0.81 PSIP1 (0.53) CA2CA1CA9CA12CA14
SCHEMBL27472338 0.73 KMT2A (0.47) CA2CA1CA9CA12CA14
SCHEMBL7570703 0.72 CA2 (0.46) CA2CA1CA9CA12CA14
SCHEMBL3612901 0.71 CA1 (0.46) CA2CA1CA9CA12CA14
Mafenide SCHEMBL41628 0.67 CA2 (1.00) CA2CA1CA9CA12CA14
Mafenide SCHEMBL9295695 0.67 CA2 (1.00) CA2CA1CA9CA12CA14
SCHEMBL4587807 0.67 HRH3 (0.42) CA2CA1CA9CA12CA14
SCHEMBL7431850 0.67
Mafenide SCHEMBL1203324 0.66 CA2 (1.00) CA2CA1CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110066231-A A kind of azepine β-substitution Morita-Baylis-Hillman type compound and its synthetic method 江苏师范大学 2019-07-30 CN disclosed
CN-102124005-B Cmet inhibitors TAKEDA PHARMACEUTICAL 2014-06-04 CN disclosed
CN-102124005-A Cmet inhibitors TAKEDA PHARMACEUTICAL 2011-07-13 CN disclosed
CN-1033454-C Preparation method of 4- [ (2-benzothiazolyl) methylamino ] -alpha- [ (3, 4-difluorophenoxy) methyl ] -1-piperidineethanol JANSSEN PHARMACEUTICA NV (BE) 1996-12-04 CN disclosed
CN-1117048-A A process for preparing an intermediate compound of the benzothiazole compounds JANSSEN PHARMACEUTICA NV (BE) 1996-02-21 CN disclosed
CN-1113437-A A process for preparing a pharmaceutical composition containing benzothiazole compounds JANSSEN PHARMACEUTICA NV (BE) 1995-12-20 CN disclosed